These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 20831551)

  • 21. Extended release quetiapine fumarate in patients with major depressive disorder: suicidality data from acute and maintenance studies.
    Weisler R; Montgomery SA; Earley WR; Szamosi J; Eriksson H
    J Clin Psychiatry; 2014 May; 75(5):520-7. PubMed ID: 24816198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quetiapine in the treatment of psychotic adolescents: a case series of 23 patients with severe early onset psychosis.
    Beer F; Heinrich H; Springer S; Rüth U; Freisleder FJ
    World J Biol Psychiatry; 2007; 8(1):38-41. PubMed ID: 17366348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Early phase II study of quetiapine fumarate on schizophrenia].
    Murasaki M; Yamauchi T; Yagi G; Nakajima T; Nakane Y; Kudo Y
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1999 Apr; 19(2):53-66. PubMed ID: 10464776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The long-term clinical benefit and effectiveness of switching to once-daily quetiapine extended release in patients with schizophrenia.
    Chue P; Malla A; Bouchard RH; Lessard S; Ganesan S; Stip E; Johnson S; Chen E; Ahn YM; Kim YS; Robinson G; Schweikert C; Gendron A; Eriksson H;
    Curr Med Res Opin; 2013 Mar; 29(3):227-39. PubMed ID: 23281876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quetiapine, a novel antipsychotic: experience in elderly patients with psychotic disorders. Seroquel Trial 48 Study Group.
    McManus DQ; Arvanitis LA; Kowalcyk BB
    J Clin Psychiatry; 1999 May; 60(5):292-8. PubMed ID: 10362435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid dose initiation of quetiapine for the treatment of acute schizophrenia and schizoaffective disorder: a randomised, multicentre, parallel-group, open study.
    Boidi G; Ferro M
    Hum Psychopharmacol; 2007 Jul; 22(5):299-306. PubMed ID: 17487936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 12-month, open-label, comparative study of quetiapine and risperidone in the acute and long-term treatment of schizophrenia.
    Perez V; Cañas F; Tafalla M;
    Int Clin Psychopharmacol; 2008 May; 23(3):138-49. PubMed ID: 18408528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subjective well-being in schizophrenia: a randomised controlled open-label 12-month non-inferiority study comparing quetiapine XR with risperidone (RECOVER).
    Naber D; Peuskens J; Schwarzmann N; Goltz M; Krüger H; Lambert M; Haro JM
    Eur Neuropsychopharmacol; 2013 Oct; 23(10):1257-69. PubMed ID: 23953270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose-dependent constipation with higher doses of quetiapine: a case series.
    Raedler TJ; Reimer J; Wiedemann K
    Int Clin Psychopharmacol; 2007 Jul; 22(4):244-6. PubMed ID: 17519649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic profile of the extended-release formulation of quetiapine fumarate (quetiapine XR): clinical implications.
    Bui K; Earley W; Nyberg S
    Curr Med Res Opin; 2013 Jul; 29(7):813-25. PubMed ID: 23574265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extended release quetiapine fumarate and pregnancy.
    Tényi T; Nagy Á; Herold R; Fekete S
    Neuropsychopharmacol Hung; 2013 Mar; 15(1):49-50. PubMed ID: 23542759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term effectiveness of quetiapine in bipolar disorder in a clinical setting.
    Ketter TA; Brooks JO; Hoblyn JC; Holland AA; Nam JY; Culver JL; Marsh WK; Bonner JC
    J Psychiatr Res; 2010 Oct; 44(14):921-9. PubMed ID: 20378127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Switching from other antipsychotics to once-daily extended release quetiapine fumarate in patients with schizophrenia.
    Ganesan S; Agambaram V; Randeree F; Eggens I; Huizar K; Meulien D;
    Curr Med Res Opin; 2008 Jan; 24(1):21-32. PubMed ID: 18021496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does quetiapine have mood altering properties?
    Mishra A; Moore PB; Hobbs R
    J Psychopharmacol; 2004 Jun; 18(2):281-4. PubMed ID: 15260919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials.
    Buckley PF
    Curr Med Res Opin; 2004 Sep; 20(9):1357-63. PubMed ID: 15383183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy and safety of once-daily quetiapine extended release in patients with schizophrenia switched from other antipsychotics: an open-label study in Chinese population.
    Pan PY; Lee MS; Yeh CB
    BMC Psychiatry; 2015 Jan; 15():1. PubMed ID: 25609320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Switching to quetiapine in patients with acute mania who were intolerant to risperidone.
    Pae CU; Lee KU; Kim JJ; Lee CU; Bahk WM; Lee SJ; Lee C; Paik IH
    Hum Psychopharmacol; 2004 Jan; 19(1):47-51. PubMed ID: 14716712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quetiapine extended release: preliminary evidence of a rapid onset of the antidepressant effect in bipolar depression.
    Porcelli S; Balzarro B; de Ronchi D; Serretti A
    J Clin Psychopharmacol; 2014 Jun; 34(3):303-6. PubMed ID: 24743712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [An open study on the efficacy and tolerability of quetiapine treatment of patients with schizophrenia].
    Beszłej JA; Grzesiak M
    Psychiatr Pol; 2005; 39(2):293-307. PubMed ID: 15881624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maintenance of long-term efficacy and safety of quetiapine in the open-label treatment of schizophrenia.
    Kasper S; Brecher M; Fitton L; Jones AM
    Int Clin Psychopharmacol; 2004 Sep; 19(5):281-9. PubMed ID: 15289701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.